ANONDITA MEDICARE LIMITED (ANONDITA) reported revenue of ₹54.00 Cr and net profit of ₹13.00 Cr for the quarter ended 2025-09-30. Figures are parsed from the company's filed results.
The statements below are read from ANONDITA MEDICARE LIMITED’s filed results, 2 filed quarters and 2 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q2 FY25-26 · filed Jul 24, 2026
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | Mar2025 | Sep2025Latest | YoYlatest |
|---|---|---|---|
| Sales | 46.0 | 54.0 | — |
| Expenses | 30.0 | 35.0 | — |
| Operating profit | 16.0 | 19.0 | — |
| OPM % | 34.8% | 35.2% | — |
| Other income | 0.00 | 0.00 | — |
| Interest | 1.00 | 2.00 | — |
| Depreciation | 0.00 | 0.00 | — |
| Profit before tax | 14.0 | 17.0 | — |
| Tax % | 28.6% | 23.5% | — |
| Net profit | 10.0 | 13.0 | — |
| EPS (₹) | 7.67 | 7.11 | — |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
